Use of oritavancin for prevention and treatment of anthrax
Details for Australian Patent Application No. 2007346657 (hide)
International Classifications
Event Publications
23 April 2009 PCT application entered the National Phase
PCT publication WO2008/097364 Priority application(s): WO2008/097364
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007346659-Metabolically engineered Escherichia coli for enchanced production of sialic acid
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser